SPIRIVA Safety Questions, SPIRIVA Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about SPIRIVA. Our extensive database of SPIRIVA adverse events and SPIRIVA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about SPIRIVA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



SPIRIVA Safety Reports

Total SPIRIVA reports: 1248.
SPIRIVA FDA safety alerts: No.
Reported deaths: 77    Reported hospitalizations: 267.
Take SPIRIVA Side Effects Survey or Share Your SPIRIVA Story. SPIRIVA Usage.

Showing 1-75 of 1248 Next >

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 03, 2006. Male patient, 53 years of age, was diagnosed with emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: viral load increased. SPIRIVA dosage: unknown. During the same period patient was treated with ALLEGRA, SYNTHROID, ASPIRIN, SALAGEN. Patient recovered.

SPIRIVA problem was reported by a Pharmacist from UNITED STATES on Aug 03, 2006. Male patient, 62 years of age, weighting 190.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. SPIRIVA dosage: unknown. During the same period patient was treated with ADVAIR, ACTOS, HYZAAR, SPIRONOLACTONE, FUROSEMIDE. Patient recovered.

Pharmacist from UNITED STATES reported SPIRIVA problem on Aug 08, 2006. Female patient, 60 years of age, was diagnosed with asthma, chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL SULPHATE INHALATION SOLUTION, FOSAMAX, NEXIUM, ADVAIR, ALLEGRA D, RANITIDINE. Patient recovered.

SPIRIVA problem was reported by a Pharmacist from UNITED STATES on Aug 03, 2006. Female patient, 68 years of age, was diagnosed with bronchitis and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, fatigue, nausea. SPIRIVA dosage: unknown. During the same period patient was treated with IRBESARTAN, HYDROCHLOROTHIAZIDE, EVISTA, ACIPHEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 03, 2006. Male patient, 32 years of age, was diagnosed with asthma, chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: nervousness, sleep disorder. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Female patient was diagnosed with asthma and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, salivary gland enlargement. SPIRIVA dosage: unknown. During the same period patient was treated with ZYRTEC, SYNTHROID, ALBUTEROL, WELLBUTRIN, TRIAMTERENE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 24, 2006. Female patient, 85 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: arthralgia, dry mouth, myalgia, vision blurred. SPIRIVA dosage: unknown. During the same period patient was treated with SPIRONOLACT, SYNTHROID, ZOLOFT, COMBIVENT, ASPIRIN. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Female patient, 83 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: anorexia, dyspepsia, flatulence, gastrooesophageal reflux disease, nausea. SPIRIVA dosage: unknown. During the same period patient was treated with DUONEB, NEURONTIN, PHAZYME. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 09, 2006. Male patient, 87 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: asthenia, malaise. SPIRIVA dosage: unknown. During the same period patient was treated with FLOMAX, LIPITOR, WATER, POTASSIUM. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Female patient, 69 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cystitis. SPIRIVA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported SPIRIVA problem on Oct 09, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: anxiety. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Male patient was diagnosed with emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: pollakiuria. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 12, 2006. Female patient, 75 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cough, increased upper airway secretion. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Health Professional from UNITED STATES on Oct 10, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Sept 01, 2006. Female patient, 72 years of age, was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, dry throat, thirst. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Pharmacist from UNITED STATES on Sept 01, 2006. Female patient, 66 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SPIRIVA dosage: unknown. During the same period patient was treated with FLOVENT, ABLUTEROL. Patient recovered.

Physician from UNITED STATES reported SPIRIVA problem on Sept 12, 2006. Female patient, 67 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dizziness, hot flush. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2006. Female patient, 48 years of age, was diagnosed with asthma and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, dysphagia, increased upper airway secretion, pharyngolaryngeal pain, sensation of foreign body, wheezing. SPIRIVA dosage: unknown. During the same period patient was treated with PROVENTIL, SEREVENT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Sept 05, 2006. Female patient was diagnosed with obstructive airways disorder and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, oral discomfort, throat irritation. SPIRIVA dosage: unknown. During the same period patient was treated with AVAPRO, ATENOLOL, HYDROCHLOROTHIAZIDE. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2006. Female patient, 72 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: chills, dry mouth, hyperhidrosis, palpitations. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL. Patient recovered.

Health Professional from UNITED STATES reported SPIRIVA problem on Sept 21, 2006. Male patient, 75 years of age, weighting 224.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, vasodilatation, vision blurred. SPIRIVA dosage: unknown. During the same period patient was treated with LANTUS, ATENOLOL, CARDURA, LYRICA, DIOVAN. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Female patient, 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: ageusia. SPIRIVA dosage: unknown. During the same period patient was treated with ADVAIR, ALBUTEROL, SINGULAIR, ATIVAN, DARVOCET, ZOCOR, DOXEPIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Sept 06, 2006. Female patient, 78 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, haematochezia, haemorrhoids. SPIRIVA dosage: unknown. During the same period patient was treated with TOPROL, LEVOTHYROXINE. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Male patient, 54 years of age, was diagnosed with chronic obstructive pulmonary disease, pulmonary congestion and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: chest discomfort. SPIRIVA dosage: unknown. During the same period patient was treated with ZYPREXA, BLOOD PRESSURE MEDICINE, ASPIRIN, PAIN RELIEVERS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 31, 2006. Female patient, 70 years of age, was diagnosed with asthma and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: muscle spasms, pain in extremity, tremor. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 31, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: chest discomfort, influenza like illness, musculoskeletal chest pain. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL, DUO NEB. Patient recovered.

SPIRIVA problem was reported by a Physician from UNITED STATES on Sept 26, 2006. Male patient, 62 years of age, weighting 120.0 lb, was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dysuria, prostatic disorder, pyrexia, urine flow decreased. SPIRIVA dosage: unknown. During the same period patient was treated with FISH OIL. Patient recovered.

Physician from UNITED STATES reported SPIRIVA problem on Sept 26, 2006. Female patient, 79 years of age, weighting 115.0 lb, was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: condition aggravated. SPIRIVA dosage: unknown. During the same period patient was treated with QVAR, SEREVENT, SEGRILINE, XANAX, DARVOCET, LISINOPRIL, LEVOTHYROXINE. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, epistaxis, peripheral vascular disorder. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 02, 2006. Female patient, 83 years of age, was diagnosed with asthma, chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: increased upper airway secretion, malaise. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Physician from UNITED STATES on Sept 29, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: pollakiuria, rash. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 02, 2006. Male patient was diagnosed with pulmonary fibrosis and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: chest discomfort. SPIRIVA dosage: unknown. During the same period patient was treated with ZOCOR, ASPIRIN, MUCINEX. Patient recovered.

SPIRIVA problem was reported by a Physician from UNITED STATES on Oct 25, 2006. Male patient, 82 years of age, weighting 220.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: eye burns, eye pruritus, haematospermia, rash, red blood cells semen. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL, FLOVENT HFA, ADVAIR DISCUS, PREDNISONE, AUGMENTIN, MONTELUKAST, THEOPHYLLINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 18, 2006. Female patient, 65 years of age, weighting 106.0 lb, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, constipation, hypersensitivity, tinnitus. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL MDI, OXYGEN, CARDIZEM, ELAVIL, DILTIAZEM, AMITRIPTYLINE, COMBIVENT. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 83 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SPIRIVA dosage: unknown. During the same period patient was treated with OXYGEN, LOVASTATIN, FUROSEMIDE, ASPIRIN, ALBUTEROL, ISOSORBIDE. Patient recovered.

Physician from UNITED STATES reported SPIRIVA problem on Oct 05, 2006. Female patient, 80 years of age, was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: visual disturbance. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, productive cough. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 29, 2006. Female patient, 59 years of age, was diagnosed with asthma, gastrooesophageal reflux disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, eructation, muscle spasms, sinusitis. SPIRIVA dosage: unknown. During the same period patient was treated with PREDNISONE, ADVAIR, ALLEGRA, PREVACID, ALBUTEROL, VITAMIN, CALCIUM. Patient recovered.

SPIRIVA problem was reported by a Physician from UNITED STATES on Sept 12, 2006. Female patient, 26 years of age, was diagnosed with obstructive airways disorder and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: chest pain, pruritus, rash, rash papular. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL INHALER. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on July 31, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. SPIRIVA dosage: unknown. During the same period patient was treated with REPORTED IN NARRATIVE. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient, 65 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: back pain, chest pain, dry mouth. SPIRIVA dosage: unknown. During the same period patient was treated with BENADRYL, OXYGEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 02, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, dry skin, dry throat, dysphonia. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Male patient was diagnosed with dyspnoea and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, pharyngolaryngeal pain. SPIRIVA dosage: unknown. During the same period patient was treated with MUCINEX, AMBIEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Sept 27, 2006. Male patient, 76 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cough, odynophagia, pharyngolaryngeal pain. SPIRIVA dosage: unknown. During the same period patient was treated with OXYGEN, IBUPROFEN, TYLENOL W, ALBUTEROL, IPRATROPIUM BROMIDE. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: somnolence. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 25, 2006. Male patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: skin laceration. SPIRIVA dosage: unknown. During the same period patient was treated with BLOOD THINNER. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Female patient, 75 years of age, was diagnosed with emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: asthenia, dysphonia, eyelid disorder. SPIRIVA dosage: unknown. During the same period patient was treated with CHOLESTEROL MEDICINE, OXYGEN, TRICOR, NORVASC, BENICAR, CLONIDINE, PROTONIX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 20, 2006. Female patient, 71 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. SPIRIVA dosage: unknown. During the same period patient was treated with OXYGEN, VERAPAMIL, FOSINOPRIL, LASIX, COUMADIN, COMBIVENT. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2006. Female patient, 85 years of age, weighting 108.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: constipation, haemorrhoidal haemorrhage. SPIRIVA dosage: unknown. During the same period patient was treated with COUMADIN, FUROSEMIDE, AMARYL, CARTIA, ALTACE, DIGOXIN, POTASSIUM CHLORIDE, RHYTHMOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Sept 28, 2006. Female patient, 86 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspepsia, glossodynia. SPIRIVA dosage: unknown. During the same period patient was treated with NORVASC, LISINOPRIL, DOXAZOSIN, ALBUTEROL. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, hypertension and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dysphagia, intracranial aneurysm, pharyngeal oedema, pyrexia. SPIRIVA dosage: unknown. During the same period patient was treated with COZAAR, VITAMIN D, CARDIZEM, INSULIN, BUMEX, ASPIRIN, ALBUTEROL, LEXAPRO. Patient recovered.

Physician from UNITED STATES reported SPIRIVA problem on Sept 28, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: lipids abnormal. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Physician from UNITED STATES on Sept 28, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: joint swelling. SPIRIVA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 17, 2006. Female patient, 75 years of age, was diagnosed with bronchiectasis, chronic obstructive pulmonary disease, extranodal marginal zone b-cell lymphoma (malt type) and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cellulitis, oral candidiasis, tongue geographic. SPIRIVA dosage: 18 MG (18 MG,1 IN 1 D),IH. During the same period patient was treated with RUTUXIN. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Male patient, 49 years of age, was diagnosed with asthma and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, dyspnoea, wheezing. SPIRIVA dosage: unknown. During the same period patient was treated with NORVASC, PEROXITINE, PRAVASTATIN, ISOSORBIDE, ASPIRIN, IBUPROFEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 18, 2006. Male patient, 48 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry mouth, dyspnoea. SPIRIVA dosage: unknown. During the same period patient was treated with FUZEON, ANTIDEPRESSANTS, ADVAIR, CPAP TREATMENTS, ALBUTEROL. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2006. Male patient, 80 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: erythema, eye pruritus, swelling face. SPIRIVA dosage: unknown. During the same period patient was treated with LASIX, FLOMAX, CALCITRIOL, PLAVIX, ATENOLOL, NORVASC, COMBIVENT, ADVAIR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 19, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: skin laceration. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: mouth ulceration. SPIRIVA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported SPIRIVA problem on Oct 18, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: aphonia. SPIRIVA dosage: unknown. During the same period patient was treated with ALPHA. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2006. Female patient, 63 years of age, weighting 150.0 lb, was diagnosed with lung infection and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: fungal infection, insomnia, lung infection, malaise, vision blurred. SPIRIVA dosage: unknown. During the same period patient was treated with CHANIX, PREDNISONE, ADVAIR DISCUS, XOPENEX, XANAX, ZYRTEC D. Patient recovered.

Health Professional from UNITED STATES reported SPIRIVA problem on Aug 25, 2006. Male patient, 51 years of age, weighting 198.0 lb, was diagnosed with asthma and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: chills, influenza like illness, muscle twitching. SPIRIVA dosage: unknown. During the same period patient was treated with GLUCOPHAGE, METFORMIN. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Male patient, 70 years of age, was diagnosed with emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. SPIRIVA dosage: unknown. During the same period patient was treated with ADVAIR, LIPITOR, ZETIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 31, 2006. Female patient, 60 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, dyspnoea. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL NEBULIZER, COMBIVENT, UNIPHYL, VOLMAX, XANAX, LORTAB, WARFARIN. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 01, 2006. Male patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: constipation, dyspnoea. SPIRIVA dosage: unknown. During the same period patient was treated with ALBUTEROL, ANDRODERM, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Aug 18, 2006. Female patient, 62 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: feeling abnormal. SPIRIVA dosage: unknown. During the same period patient was treated with METHOTREXATE, ACTONEL, ADVAIR, THYROID, FOLIC ACID, CALCIUM. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Male patient, 79 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspepsia, eructation. SPIRIVA dosage: unknown. During the same period patient was treated with ATROVENT, LISINOPRIL, DIGOXIN, FUROSEMIDE, PLAVIX, METOPROLOL TARTRATE, ZOCOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Sept 20, 2006. Male patient, 70 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SPIRIVA dosage: unknown. During the same period patient was treated with PREDNISONE, ALBUTEROL. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: ageusia. SPIRIVA dosage: unknown. During the same period patient was treated with ADVAIR. Patient recovered.

Pharmacist from UNITED STATES reported SPIRIVA problem on Oct 23, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: asthma. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: feeling jittery, nausea. SPIRIVA dosage: unknown. During the same period patient was treated with IPRATROPIUM BROMIDE, ZOPINEX. Patient recovered.

Physician from UNITED STATES reported SPIRIVA problem on Oct 20, 2006. Female patient was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. SPIRIVA dosage: unknown. Patient recovered.

SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Male patient was diagnosed with emphysema and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: anxiety, psychomotor hyperactivity, total lung capacity decreased. SPIRIVA dosage: unknown. During the same period patient was treated with PREDNISONE, AZMACORT, THEOPHYLLINE, ALBUTEROL INHALER. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Oct 25, 2006. Female patient, 77 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: dry eye, eye pruritus, skin disorder, vision blurred. SPIRIVA dosage: unknown. During the same period patient was treated with THYROID. Patient recovered.

Showing 1-75 of 1248 Next >

Ask Our Patient Community about SPIRIVA

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
Phenergan